Kwon J, Zhang J, Mok B, Allsup S, Kim C, Toretsky J, Han C.
Mol Cancer. 2023 Dec 13;22(1):204. doi: 10.1186/s12943-023-01892-x. [Full-text]
CK2-mediated phosphorylation upregulates the stability of USP13 and promotes ovarian cancer cell proliferation.
Kwon J, Zhang J, Mok B, Han C.
Cancers (Basel). 2022 Dec 29;15(1):200. doi: 10.3390/cancers15010200. [Full text]
USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model.
Kwon J, Choi H, Ware AD, Morillo BC, Wang H, Bouker KB, Lu X, Waldman T, Han C.
Oncogene. 2022 Mar;41(13):1974-1985. doi: 10.1038/s41388-022-02224-x. [Full text]
Targeting DDX3X triggers antitumor immunity via a dsRNA-mediated tumor-intrinsic type I Iinterferon response.
Choi H, Kwon J, Cho MS, Sun Y, Zheng X, Wang J, Bouker KB, Casey JL, Atkins MB, Toretsky J, Han C.
Cancer Res. 2021 Jul 1;81(13):3607-3620. doi: 10.1158/0008-5472.CAN-20-3790.
Quantitative difference in PLZF protein expression determines iNKT lineage fate and controls innate CD8 T cell generation.
Park JY, DiPalma DT, Kwon J, Fink J, Park JH.
Cell Rep. 2019 May 28;27(9):2548-2557.e4. doi: 10.1016/j.celrep.2019.05.012. [Full text]
TEX13 is a novel male germ cell-specific nuclear protein potentially involved in transcriptional repression.
Kwon JT, Jin S, Choi H, Kim J, Jeong J, Kim J, Cho C.
FEBS Lett. 2016 Oct;590(20):3526-3537. doi: 10.1002/1873-3468.12433. [Full text]